{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:38:16Z","timestamp":1774424296035,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long non-coding ribonucleic acids (LncRNAs) are larger than 200 nucleotides and resemble messenger ribonucleic acids (mRNAs), but they do not code for proteins. In both cell development and physiological cell function, LncRNAs have crucial biological functions. Consequently, cancer entails the disruption of their biological function. Many people die from lung cancer because it is diagnosed late, spreads to other parts of the body, and has a high treatment failure rate. Because they can be involved in either oncogenic or tumor-suppressing functions, LncRNAs are quickly becoming core molecules in lung cancer. Since LncRNAs are long-lasting in blood, they can be utilized as non-invasive diagnostic tools for cancer at an early stage. We review the latest research that has brought together evidence from real-world observations concerning the processes through which LncRNAs work in cancer formation, how they allow cancer to develop drug resistance, and how they can be used as possible diagnostic tools and markers of outcome, with a focus on lung cancer. We also cover some of the ongoing treatment strategies that can target LncRNAs. As seen from what has been laid out here, the examination of LncRNAs in lung cancer with protein-coding genes could provide evidence for a further elucidation of the molecular events behind the disease as well as its progression, and the potential for a new therapeutic pathway.<\/jats:p>","DOI":"10.1186\/s43046-025-00327-6","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:02:37Z","timestamp":1761498157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unraveling LncRNAs: the future of lung cancer treatment"],"prefix":"10.1186","volume":"37","author":[{"given":"Zahraa Isam","family":"Jameel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halla","family":"Abdul-Hadi Chabuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"327_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr., Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8.","journal-title":"Lancet"},{"key":"327_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1709937.","journal-title":"N Engl J Med"},{"key":"327_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0140-6736(13)61715-8","volume":"382","author":"R Rosell","year":"2013","unstructured":"Rosell R, Bivona TG, Karachaliou N. Genetics and biomarkers in personalisation of lung cancer treatment. Lancet. 2013;382:720\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(13)61715-8.","journal-title":"Lancet"},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","volume":"5","author":"D Morgensztern","year":"2010","unstructured":"Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5:29\u201333.","journal-title":"J Thorac Oncol"},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1038\/s41467-022-34252-2","volume":"13","author":"MS Leisegang","year":"2022","unstructured":"Leisegang MS, Bains JK, Seredinski S, Oo JA, Krause NM, Kuo CC, Gunther S, Sentruk Cetin N, Warwick T, Cao C, et al. HIF1alpha-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex. Nat Commun. 2022;13:6563.","journal-title":"Nat Commun"},{"key":"327_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.celrep.2015.03.043","volume":"11","author":"VB O\u2019Leary","year":"2015","unstructured":"O\u2019Leary VB, Ovsepian SV, Carrascosa LG, Buske FA, Radulovic V, Niyazi M, et al. PARTICLE, a triplex-forming long ncRNA, regulates locus-specific methylation in response to low-dose irradiation. Cell Rep. 2015;11:474\u201385.","journal-title":"Cell Rep"},{"key":"327_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.omtn.2022.09.016","volume":"30","author":"I Rakheja","year":"2022","unstructured":"Rakheja I, Ansari AH, Ray A, Chandra Joshi D, Maiti S. Small molecule quercetin binds MALAT1 triplex and modulates its cellular function. Mol Ther Nucleic Acids. 2022;30:241\u201356.","journal-title":"Mol Ther Nucleic Acids"},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee J. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651\u201369.","journal-title":"Genetics"},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21:542\u201351.","journal-title":"Nat Cell Biol"},{"key":"327_CR11","doi-asserted-by":"crossref","unstructured":"Shen S, Chen J, Li H, Jiang Y, Wei Y, Zhang R, et al. Large-scale integration of the non-coding RNAs with DNA methylation in human cancers. Cell Rep. 2023;42:112261.","DOI":"10.1016\/j.celrep.2023.112261"},{"key":"327_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"B Chen","year":"2022","unstructured":"Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022;7:121.","journal-title":"Signal Transduct Target Ther"},{"key":"327_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao2110","volume":"3","author":"Y Long","year":"2017","unstructured":"Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv. 2017;3:eaao2110.","journal-title":"Sci Adv"},{"key":"327_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1101\/gad.17446611","volume":"25","author":"MN Cabili","year":"2011","unstructured":"Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915\u201327.","journal-title":"Genes Dev"},{"key":"327_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14:42\u201354. https:\/\/doi.org\/10.1016\/j.gpb.2015.09.006.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"327_CR16","volume":"2012","author":"KS Enfield","year":"2012","unstructured":"Enfield KS, Pikor LA, Martinez VD, Lam WL. Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications. Genet Res Int. 2012;2012:737416.","journal-title":"Genet Res Int"},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2017.11.005","volume":"34","author":"Q Sun","year":"2018","unstructured":"Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34:142\u201357. https:\/\/doi.org\/10.1016\/j.tig.2017.11.005.","journal-title":"Trends Genet"},{"key":"327_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1471","volume":"9","author":"JH Noh","year":"2018","unstructured":"Noh JH, Kim KM, McClusky WG, Abdelmohsen K, Gorospe M. Cytoplasmic functions of long noncoding RNAs. WIREs RNA. 2018;9:e1471.","journal-title":"WIREs RNA"},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/cncr.31551","volume":"124","author":"KA Cronin","year":"2018","unstructured":"Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2018;124:2785\u2013800.","journal-title":"Cancer"},{"key":"327_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molmed.2018.12.009","volume":"25","author":"AJ Sabnis","year":"2019","unstructured":"Sabnis AJ, Bivona TG. Principles of resistance to targeted cancer therapy: lessons from basic and translational cancer biology. Trends Mol Med. 2019;25:185\u201397.","journal-title":"Trends Mol Med"},{"key":"327_CR21","first-page":"670","volume":"23","author":"SS Chen","year":"2019","unstructured":"Chen SS, Peng M, Zhou GZ, Pu YC, Yi MC, Zhu Y, et al. Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217\/DACH1 signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:670\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"327_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.528520","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Cui Z, Lv X, Li J, Gao M, Yang Z, et al. Long non-coding RNA HOTAIR function as a competing endogenous RNA for miR-149-5p to promote the cell growth, migration, and invasion in non-small cell lung cancer. Front Oncol. 2020;10:528520.","journal-title":"Front Oncol"},{"key":"327_CR23","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1002\/jcp.26325","volume":"233","author":"S Li","year":"2018","unstructured":"Li S, Mei Z, Hu HB, Zhang X. The lncrna MALAT1 contributes to non-small cell lung cancer development via modulating miR-124\/STAT3 axis. J Cell Physiol. 2018;233:6679\u201388.","journal-title":"J Cell Physiol"},{"key":"327_CR24","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.1002\/cam4.3570","volume":"9","author":"D Wang","year":"2020","unstructured":"Wang D, Zhang S, Zhao M, Chen F. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p\/MDM4 axis. Cancer Med. 2020;9:9138\u201349.","journal-title":"Cancer Med"},{"key":"327_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/OTT.S186607","volume":"12","author":"L Guo","year":"2019","unstructured":"Guo L, Gu J, Hou S, Liu D, Zhou M, Hua T, et al. Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression. Onco Targets Ther. 2019;12:135\u201346.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"327_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA. Micrornas and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847\u201365. https:\/\/doi.org\/10.1038\/nrd4140.","journal-title":"Nat Rev Drug Discov"},{"key":"327_CR27","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/biom10121646","volume":"10","author":"JE Yu","year":"2020","unstructured":"Yu JE, Ju JA, Musacchio N, Mathias TJ, Vitolo MI. Long noncoding RNA DANCR activates Wnt\/beta-catenin signaling through MiR-216a inhibition in non-small cell lung cancer. Biomolecules. 2020;10:1646.","journal-title":"Biomolecules"},{"key":"327_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/carcin\/bgz125","volume":"41","author":"M Jin","year":"2020","unstructured":"Jin M, Ren J, Luo M, You Z, Fang Y, Han Y, et al. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2. Carcinogenesis. 2020;41:634\u201345.","journal-title":"Carcinogenesis"},{"key":"327_CR29","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1002\/jcp.26543","volume":"233","author":"B Jin","year":"2018","unstructured":"Jin B, Jin H, Wu HB, Xu JJ, Li B. Long non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to accelerate non-small cell lung cancer cells progression and metastasis. J Cell Physiol. 2018;233:7164\u201372.","journal-title":"J Cell Physiol"},{"key":"327_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/aps.2016.133","volume":"38","author":"YL Zhang","year":"2017","unstructured":"Zhang YL, Li XB, Hou YX, Fang NZ, You JC, Zhou QH. The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer. Acta Pharmacol Sin. 2017;38:371\u201381.","journal-title":"Acta Pharmacol Sin"},{"key":"327_CR31","first-page":"5938","volume":"22","author":"JL Wu","year":"2018","unstructured":"Wu JL, Meng FM, Li HJ. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p. Eur Rev Med Pharmacol Sci. 2018;22:5938\u201345.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"327_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41389-020-0217-0","volume":"9","author":"Z Xiufen","year":"2020","unstructured":"Xiufen Z, Junying Z, Tian F, Xiaoxiao W, Siwei W, Zhifei M, et al. The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway. Oncogenesis. 2020;9:34.","journal-title":"Oncogenesis"},{"key":"327_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2147\/OTT.S235336","volume":"13","author":"H Geng","year":"2020","unstructured":"Geng H, Li S, Xu M. Long noncoding RNA SNHG6 functions as an oncogene in non-small cell lung cancer via modulating ETS1 signaling. Onco Targets Ther. 2020;13:921\u201330.","journal-title":"Onco Targets Ther"},{"key":"327_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/1759-7714.13371","volume":"11","author":"K Li","year":"2020","unstructured":"Li K, Jiang Y, Xiang X, Gong Q, Zhou C, Zhang L, et al. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p. Thorac Cancer. 2020;11:1180\u201390.","journal-title":"Thorac Cancer"},{"key":"327_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cca.2019.11.031","volume":"504","author":"Z Chen","year":"2020","unstructured":"Chen Z, Lei T, Chen X, Gu J, Huang J, Lu B, et al. Long non-coding RNA in lung cancer. Clin Chim Acta. 2020;504:190\u2013200.","journal-title":"Clin Chim Acta"},{"key":"327_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-461","volume":"13","author":"KH Lu","year":"2013","unstructured":"Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu WQ, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.","journal-title":"BMC Cancer"},{"key":"327_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11830","volume":"23","author":"D Lv","year":"2021","unstructured":"Lv D, Bi Q, Li Y, Deng J, Wu N, Hao S, et al. Long non-coding RNA MEG3 inhibits cell migration and invasion of non-small cell lung cancer cells by regulating the miR-21-5p\/PTEN axis. Mol Med Rep. 2021;23:191.","journal-title":"Mol Med Rep"},{"issue":"Suppl 1","key":"327_CR38","first-page":"E1","volume":"54","author":"X Shi","year":"2015","unstructured":"Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. 2015;54(Suppl 1):E1-12.","journal-title":"Mol Carcinog"},{"key":"327_CR39","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.12659\/MSM.912581","volume":"25","author":"L Dong","year":"2019","unstructured":"Dong L, Li G, Li Y, Zhu Z. Upregulation of long noncoding RNA GAS5 inhibits lung cancer cell proliferation and metastasis via miR-205\/PTEN axis. Med Sci Monit. 2019;25:2311\u20139.","journal-title":"Med Sci Monit"},{"key":"327_CR40","doi-asserted-by":"publisher","first-page":"25558","DOI":"10.18632\/oncotarget.8338","volume":"7","author":"X Shi","year":"2016","unstructured":"Shi X, Ma C, Zhu Q, Yuan D, Sun M, Gu X, et al. Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer. Oncotarget. 2016;7:25558\u201375.","journal-title":"Oncotarget"},{"key":"327_CR41","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1080\/15384101.2018.1467675","volume":"17","author":"Y Tian","year":"2018","unstructured":"Tian Y, Zhang N, Chen S, Ma Y, Liu Y. The long non-coding RNA LSINCT5 promotes malignancy in non-small cell lung cancer by stabilizing HMGA2. Cell Cycle. 2018;17:1188\u201398.","journal-title":"Cell Cycle"},{"key":"327_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13046-017-0518-0","volume":"36","author":"Z Lu","year":"2017","unstructured":"Lu Z, Li Y, Wang J, Che Y, Sun S, Huang J, et al. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-kappaB\/Snail pathway. J Exp Clin Cancer Res. 2017;36:54.","journal-title":"J Exp Clin Cancer Res"},{"key":"327_CR43","first-page":"2595","volume":"12","author":"D Liu","year":"2019","unstructured":"Liu D, Shi X. Long non-coding RNA NKILA inhibits proliferation and migration of lung cancer via IL-11\/STAT3 signaling. Int J Clin Exp Pathol. 2019;12:2595\u2013603.","journal-title":"Int J Clin Exp Pathol"},{"key":"327_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12312","volume":"50","author":"J Li","year":"2017","unstructured":"Li J, Lian Y, Yan C, Cai Z, Ding J, Ma Z, et al. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer. Cell Prolif. 2017;50:e12312.","journal-title":"Cell Prolif"},{"key":"327_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"327_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrm2434","volume":"9","author":"YP Ow","year":"2008","unstructured":"Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol. 2008;9:532\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"327_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-021-00407-1","volume":"7","author":"N Jiang","year":"2021","unstructured":"Jiang N, Zhang X, Gu X, Li X, Shang L. Progress in understanding the role of lncRNA in programmed cell death. Cell Death Discov. 2021;7:30.","journal-title":"Cell Death Discov"},{"key":"327_CR48","first-page":"10354","volume":"23","author":"B Han","year":"2019","unstructured":"Han B. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p\/SEC61G. Eur Rev Med Pharmacol Sci. 2019;23:10354\u201362.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"327_CR49","first-page":"2280","volume":"24","author":"T Wang","year":"2019","unstructured":"Wang T, Tang X, Liu Y. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a\/beta-catenin. J BUON. 2019;24:2280\u20136.","journal-title":"J BUON"},{"key":"327_CR50","doi-asserted-by":"publisher","first-page":"109858","DOI":"10.1016\/j.biopha.2020.109858","volume":"124","author":"Z Yang","year":"2020","unstructured":"Yang Z, Lin X, Zhang P, Liu Y, Liu Z, Qian B, et al. RETRACTED: long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338\u20133p\/IRS2 axis. Biomed Pharmacother. 2020;124:109858.","journal-title":"Biomed Pharmacother"},{"key":"327_CR51","doi-asserted-by":"publisher","first-page":"e2300314","DOI":"10.1002\/advs.202300314","volume":"10","author":"H Pei","year":"2023","unstructured":"Pei H, Dai Y, Yu Y, Tang J, Cao Z, Zhang Y, et al. The tumorigenic effect of lncRNA AFAP1-AS1 is mediated by translated peptide ATMLP under the control of m(6) A methylation. Adv Sci (Weinh). 2023;10:e2300314.","journal-title":"Adv Sci (Weinh)"},{"key":"327_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/b978-0-12-420117-0.00008-6","volume":"122","author":"HM Leinonen","year":"2014","unstructured":"Leinonen HM, Kansanen E, Polonen P, Heinaniemi M, Levonen AL. Role of the Keap1-Nrf2 pathway in cancer. Adv Cancer Res. 2014;122:281\u2013320. https:\/\/doi.org\/10.1016\/b978-0-12-420117-0.00008-6.","journal-title":"Adv Cancer Res"},{"issue":"4","key":"327_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/gcc.22032","volume":"52","author":"E Zandberga","year":"2013","unstructured":"Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer. 2013;52(4):356\u201369. https:\/\/doi.org\/10.1002\/gcc.22032.","journal-title":"Genes Chromosomes Cancer"},{"key":"327_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-518","volume":"6","author":"DG Weber","year":"2013","unstructured":"Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6:518. https:\/\/doi.org\/10.1186\/1756-0500-6-518.","journal-title":"BMC Res Notes"},{"issue":"7291","key":"327_CR55","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071\u20136. https:\/\/doi.org\/10.1038\/nature08975.","journal-title":"Nature"},{"key":"327_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-7-69","volume":"7","author":"A Mizrahi","year":"2009","unstructured":"Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009;7:69. https:\/\/doi.org\/10.1186\/1479-5876-7-69.","journal-title":"J Transl Med"},{"issue":"11","key":"327_CR57","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1158\/0008-5472.can-10-4460","volume":"71","author":"D Khaitan","year":"2011","unstructured":"Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71(11):3852\u201362. https:\/\/doi.org\/10.1158\/0008-5472.can-10-4460.","journal-title":"Cancer Res"},{"key":"327_CR58","doi-asserted-by":"publisher","unstructured":"Alasadi YF, Jameel ZI. Single nucleotide polymorphism of gene IL8\u2013251A\/T (RS4073) associate with coronary artery disease. Int J Pharm Res. 2020; 12(sp2). https:\/\/doi.org\/10.31838\/ijpr\/2020.sp2.131.","DOI":"10.31838\/ijpr\/2020.sp2.131"},{"issue":"12","key":"327_CR59","doi-asserted-by":"publisher","first-page":"11653","DOI":"10.1007\/s11033-022-07933-w","volume":"49","author":"ZK Lawi","year":"2022","unstructured":"Lawi ZK, Al-Shuhaib MB, Amara IB, Alkhammas AH. Two missense variants of the epidermal growth factor receptor gene are associated with non small cell lung carcinoma in the subjects from Iraq. Mol Biol Rep. 2022;49(12):11653\u201361. https:\/\/doi.org\/10.1007\/s11033-022-07933-w.","journal-title":"Mol Biol Rep"},{"key":"327_CR60","first-page":"188491","volume":"1875","author":"S Toden","year":"2021","unstructured":"Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta. 2021;1875:188491.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"327_CR61","doi-asserted-by":"publisher","first-page":"694","DOI":"10.5937\/jomb0-41553","volume":"42","author":"Z Lawi","year":"2023","unstructured":"Lawi Z, Alkhammas A, Elerouri M, Ben A, Al-Shuhaib M. Two co-inherited SNPs of the telomerase reverse transcriptase (TERT) gene are associated with Iraqi patients with lung cancer. J Med Biochem. 2023;42(4):694\u2013705. https:\/\/doi.org\/10.5937\/jomb0-41553.","journal-title":"J Med Biochem"},{"key":"327_CR62","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2015.08.011","volume":"219","author":"D Wen","year":"2015","unstructured":"Wen D, Danquah M, Chaudhary AK, Mahato RI. Small molecules targeting microrna for cancer therapy: promises and obstacles. J Control Release. 2015;219:237\u201347.","journal-title":"J Control Release"},{"key":"327_CR63","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14737159.2016.1156535","volume":"16","author":"OA Tovar- Camargo","year":"2016","unstructured":"Tovar-Camargo OA, Toden S, Goel A. Exosomal microrna biomarkers: emerging frontiers in colorectal and other human cancers. Expert Rev Mol Diagn. 2016;16:553\u201367.","journal-title":"Expert Rev Mol Diagn"},{"key":"327_CR64","doi-asserted-by":"crossref","unstructured":"Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB, Gupta SC. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Biophys Acta. 2021;1875:188502.","DOI":"10.1016\/j.bbcan.2021.188502"},{"key":"327_CR65","doi-asserted-by":"publisher","unstructured":"Sharma U, Barwal TS, Malhotra A, Pant N, Vivek, Dey D et al. Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer. Life Sci. 2020;257:118035. https:\/\/doi.org\/10.1016\/j.lfs.2020.118035.","DOI":"10.1016\/j.lfs.2020.118035"},{"key":"327_CR66","doi-asserted-by":"publisher","first-page":"543","DOI":"10.18632\/oncotarget.28447","volume":"14","author":"V Feichtenschlager","year":"2023","unstructured":"Feichtenschlager V, Zheng YJ, Ho W, Chen L, Callanan C, Chen C, et al. Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget. 2023;14:543\u201360.","journal-title":"Oncotarget"},{"key":"327_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","volume":"29","author":"L Qu","year":"2016","unstructured":"Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653\u201368.","journal-title":"Cancer Cell"},{"key":"327_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15547-8","volume":"11","author":"JM Silva-Fisher","year":"2020","unstructured":"Silva-Fisher JM, Dang HX, White NM, Strand MS, Krasnick BA, Rozycki EB, et al. Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression. Nat Commun. 2020;11:2156.","journal-title":"Nat Commun"},{"key":"327_CR69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12935-021-02023-6","volume":"21","author":"MZ Islam Khan","year":"2021","unstructured":"Islam Khan MZ, Law HKW. RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition. Cancer Cell Int. 2021;21:321.","journal-title":"Cancer Cell Int"},{"key":"327_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ncb3464","volume":"19","author":"C Li","year":"2017","unstructured":"Li C, Wang S, Xing Z, Lin A, Liang K, Song J, et al. A ror1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19:106\u201319.","journal-title":"Nat Cell Biol"},{"key":"327_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/ncb3467","volume":"19","author":"W Zhuo","year":"2017","unstructured":"Zhuo W, Kang Y. Lnc-ing ROR1-HER3 and Hippo signalling in metastasis. Nat Cell Biol. 2017;19:81\u20133.","journal-title":"Nat Cell Biol"},{"key":"327_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. M(6)a modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270\u201388.","journal-title":"Cancer Cell"},{"key":"327_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629\u201351.","journal-title":"Nat Rev Drug Discov"},{"key":"327_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100177","volume":"2","author":"D Wu","year":"2022","unstructured":"Wu D, Poddar A, Ninou E, Hwang E, Cole MA, Liu SJ, et al. Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells. Cell Genom. 2022;2:100177.","journal-title":"Cell Genom"},{"issue":"4","key":"327_CR75","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.31018\/jans.v13i4.3024","volume":"13","author":"HA-H Chabuk","year":"2021","unstructured":"Chabuk HA-H, Jameel ZI. Relationship between the monoamine oxidase gene overactivity and the other pathophysiological and behavioral parameters implicated in memory deficiency in albino Winstar rats as Alzheimer\u2019s disease model. J Appl Nat Sci. 2021;13(4):1274\u201382. https:\/\/doi.org\/10.31018\/jans.v13i4.3024.","journal-title":"J Appl Nat Sci"},{"key":"327_CR76","doi-asserted-by":"publisher","unstructured":"Ghalib RA, Awadh RM, Jameel ZI. Investigation of CASR gene polymorphism in the patients with hypothyroidism disease in Babylon Province. Int J Pharm Qual Assur. 2019;10(02). https:\/\/doi.org\/10.25258\/ijpqa.10.2.3.92.","DOI":"10.25258\/ijpqa.10.2.3.92"},{"issue":"1","key":"327_CR77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.22159\/ajpcr.2018.v11i1.22063","volume":"11","author":"Z Isam","year":"2018","unstructured":"Isam Z, Al-jelawi- RO, Mahmood AH. Detection single nucleotide polymorphisms in uromodulin promoter region associated with renal diseases using single-strand conformation polymorphism-polymerase chain polymorphisms technique. Asian J Pharm Clin Res. 2018;11(1):205. https:\/\/doi.org\/10.22159\/ajpcr.2018.v11i1.22063.","journal-title":"Asian J Pharm Clin Res"},{"issue":"2","key":"327_CR78","doi-asserted-by":"publisher","first-page":"417","DOI":"10.22159\/ajpcr.2018.v11i2.22064","volume":"11","author":"Z Isam","year":"2018","unstructured":"Isam Z, Omran R, Mahmood AH. Single-nucleotide polymorphisms of calcium-sensing receptor encoding gene associated with calcium kidney stone disease in Babylon Province. Asian J Pharm Clin Res. 2018;11(2):417. https:\/\/doi.org\/10.22159\/ajpcr.2018.v11i2.22064.","journal-title":"Asian J Pharm Clin Res"},{"issue":"Supplement 1","key":"327_CR79","first-page":"2027","volume":"19","author":"ZI Jameel","year":"2019","unstructured":"Jameel ZI, Lawi ZK, Al-Dujaili NH. Investigation of micro RNA gene polymorphism (Rs11614913) inpatients with type 2 diabetes in Najaf city. Biochem Cell Arch. 2019;19(Supplement 1):2027\u201330.","journal-title":"Biochem Cell Arch"},{"key":"327_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-024-00521-6","author":"ZI Jameel","year":"2024","unstructured":"Jameel ZI. Four microrna gene polymorphisms are associated with Iraqi patients with colorectal cancer. Egypt J Med Hum Genet. 2024. https:\/\/doi.org\/10.1186\/s43042-024-00521-6.","journal-title":"Egypt J Med Hum Genet"},{"key":"327_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cancergen.2025.02.006","volume":"292","author":"ZI Jameel","year":"2025","unstructured":"Jameel ZI. Three FGFR4 gene polymorphisms contribute to the susceptibility of urethral cancer in the middle and south of Iraq population. Cancer Genet. 2025;292:77\u201384. https:\/\/doi.org\/10.1016\/j.cancergen.2025.02.006.","journal-title":"Cancer Genet"},{"issue":"2","key":"327_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.repbre.2025.03.004","volume":"5","author":"ZI Jameel","year":"2025","unstructured":"Jameel ZI. SNPs variety of 3-\u03b2-hydroxysteroid dehydrogenase 1 (HSD3B1) gene are related to prostate cancer in some Iraqi individuals. Reprod Breed. 2025;5(2):37\u201343. https:\/\/doi.org\/10.1016\/j.repbre.2025.03.004.","journal-title":"Reprod Breed"},{"key":"327_CR83","doi-asserted-by":"publisher","unstructured":"Jameel ZI, Kareem HA, Yahya ZM, Hussein AA, Kareem ZA. Association of MIR196A2 and mir146a polymorphisms and colorectal cancer risk: a meta-analysis. Hum Gene. 2025;45:201448. https:\/\/doi.org\/10.1016\/j.humgen.2025.201448.","DOI":"10.1016\/j.humgen.2025.201448"},{"key":"327_CR84","doi-asserted-by":"publisher","unstructured":"Al Shammari A, Isam Z, Banimuslem T, Neamaa A. Investigation of microRNA 196A2 polymorphism with thalassemia disease among middle and South Iraqi population. Jordan Med J. 2025;59(2). https:\/\/doi.org\/10.35516\/jmj.v59i2.1980.","DOI":"10.35516\/jmj.v59i2.1980"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00327-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:02:40Z","timestamp":1761498160000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00327-6","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}